Announcement of the consolidated financial report for the 2nd quarter of 2022 approved by the board of directors
· Issued by Nang Kuang Pharmaceutical Co., Ltd.
Close
Today's Information
Provided by: NANG KUANG PHARMACECUTICAL CO., LTD
SEQ_NO
1
Date of announcement
2022/08/03
Time of announcement
18:01:09
Subject
Announcement of the consolidated financial report for the
2nd quarter of 2022 approved by the board of directors
Date of events
2022/08/03
To which item it meets
paragraph 31
Statement
1.Date of submission to the board of directors or approval by the board of
directors:2022/08/03
2.Date of approval by the audit committee:2022/08/03
3.Start and end dates of financial reports or annual self-assessed financial
information of the reporting period (XXXX/XX/XX~XXXX/XX/XX):
2022/01/01~2022/06/30
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):848609
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):301992
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):125970
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):138192
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):115627
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):115627
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):1.14
11.Total assets end of the period (thousand NTD):3415786
12.Total liabilities end of the period
(thousand NTD):1241730
13.Equity attributable to owners of parent end of the
period (thousand NTD):2174056
14.Any other matters that need to be specified:None.
